Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-center, Proof of Concept, Prospective Study Evaluating the Utility of RELiZORB™ for the Treatment of Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure

NCT05710315 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT05710315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05710315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-center, Proof of Concept, Prospective Study Evaluating the Utility of RELiZORB™ for the Treatment of Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
Lead sponsor
Inova Health Care Services
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 7, 2025
Completion date
December 31, 2026
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exocrine pancreatic insufficiency, multi organ failure